243 related articles for article (PubMed ID: 22102888)
1. Serum fatty acid-binding protein 4 is a predictor of cardiovascular events in end-stage renal disease.
Furuhashi M; Ishimura S; Ota H; Hayashi M; Nishitani T; Tanaka M; Yoshida H; Shimamoto K; Hotamisligil GS; Miura T
PLoS One; 2011; 6(11):e27356. PubMed ID: 22102888
[TBL] [Abstract][Full Text] [Related]
2. Elevation of fatty acid-binding protein 4 is predisposed by family history of hypertension and contributes to blood pressure elevation.
Ota H; Furuhashi M; Ishimura S; Koyama M; Okazaki Y; Mita T; Fuseya T; Yamashita T; Tanaka M; Yoshida H; Shimamoto K; Miura T
Am J Hypertens; 2012 Oct; 25(10):1124-30. PubMed ID: 22717543
[TBL] [Abstract][Full Text] [Related]
3. Plasma-free fatty acids, fatty acid-binding protein 4, and mortality in older adults (from the Cardiovascular Health Study).
Miedema MD; Maziarz M; Biggs ML; Zieman SJ; Kizer JR; Ix JH; Mozaffarian D; Tracy RP; Psaty BM; Siscovick DS; Mukamal KJ; Djousse L
Am J Cardiol; 2014 Sep; 114(6):843-8. PubMed ID: 25073566
[TBL] [Abstract][Full Text] [Related]
4. Elevated circulating FABP4 concentration predicts cardiovascular death in a general population: a 12-year prospective study.
Saito N; Furuhashi M; Koyama M; Higashiura Y; Akasaka H; Tanaka M; Moniwa N; Ohnishi H; Saitoh S; Ura N; Shimamoto K; Miura T
Sci Rep; 2021 Feb; 11(1):4008. PubMed ID: 33597568
[TBL] [Abstract][Full Text] [Related]
5. Adipose-Derived Fatty Acid-Binding Proteins Plasma Concentrations Are Increased in Breast Cancer Patients.
Guaita-Esteruelas S; Saavedra-García P; Bosquet A; Borràs J; Girona J; Amiliano K; Rodríguez-Balada M; Heras M; Masana L; Gumà J
Oncologist; 2017 Nov; 22(11):1309-1315. PubMed ID: 28701570
[TBL] [Abstract][Full Text] [Related]
6. Elevation of circulating fatty acid-binding protein 4 is independently associated with left ventricular diastolic dysfunction in a general population.
Fuseya T; Furuhashi M; Yuda S; Muranaka A; Kawamukai M; Mita T; Ishimura S; Watanabe Y; Hoshina K; Tanaka M; Ohno K; Akasaka H; Ohnishi H; Yoshida H; Saitoh S; Shimamoto K; Miura T
Cardiovasc Diabetol; 2014 Aug; 13():126. PubMed ID: 25142635
[TBL] [Abstract][Full Text] [Related]
7. Serum retinol-binding protein 4 as a marker for cardiovascular disease in women.
Alkharfy KM; Al-Daghri NM; Vanhoutte PM; Krishnaswamy S; Xu A
PLoS One; 2012; 7(10):e48612. PubMed ID: 23119072
[TBL] [Abstract][Full Text] [Related]
8. Circulating Fatty Acid-Binding Protein 4 Concentration Predicts the Progression of Carotid Atherosclerosis in a General Population Without Medication.
Furuhashi M; Yuda S; Muranaka A; Kawamukai M; Matsumoto M; Tanaka M; Moniwa N; Ohnishi H; Saitoh S; Shimamoto K; Miura T
Circ J; 2018 Mar; 82(4):1121-1129. PubMed ID: 29445067
[TBL] [Abstract][Full Text] [Related]
9. Circulating adipocyte fatty acid-binding protein is a predictor of cardiovascular events in patients with stable angina undergoing percutaneous coronary intervention.
Takagi W; Miyoshi T; Doi M; Okawa K; Nosaka K; Nishibe T; Matsuo N; Hirohata S; Ito H
BMC Cardiovasc Disord; 2017 Oct; 17(1):258. PubMed ID: 29017449
[TBL] [Abstract][Full Text] [Related]
10. Fatty Acid Binding Protein-4 and Risk of Cardiovascular Disease: The Cardiovascular Health Study.
Egbuche O; Biggs ML; Ix JH; Kizer JR; Lyles MF; Siscovick DS; Djoussé L; Mukamal KJ
J Am Heart Assoc; 2020 Apr; 9(7):e014070. PubMed ID: 32248728
[TBL] [Abstract][Full Text] [Related]
11. Elevated serum fatty acid-binding protein 4 level predicts all-cause and cardiovascular mortality in peritoneal dialysis patients: a five-year study.
Zhou S; Wang X; Han Q; He L; Tang W; Zhang A
Ren Fail; 2023; 45(2):2262624. PubMed ID: 37782286
[TBL] [Abstract][Full Text] [Related]
12. Increase in skin autofluorescence and release of heart-type fatty acid binding protein in plasma predicts mortality of hemodialysis patients.
Arsov S; Trajceska L; van Oeveren W; Smit AJ; Dzekova P; Stegmayr B; Sikole A; Rakhorst G; Graaff R
Artif Organs; 2013 Jul; 37(7):E114-22. PubMed ID: 23635017
[TBL] [Abstract][Full Text] [Related]
13. Association of Adiponectin With Body Composition and Mortality in Hemodialysis Patients.
Rhee CM; Nguyen DV; Moradi H; Brunelli SM; Dukkipati R; Jing J; Nakata T; Kovesdy CP; Brent GA; Kalantar-Zadeh K
Am J Kidney Dis; 2015 Aug; 66(2):313-21. PubMed ID: 25824125
[TBL] [Abstract][Full Text] [Related]
14. Plasma fatty acid-binding protein 4 (FABP4) level is associated with abnormal QTc interval in patients with stable angina and chronic kidney disease.
Wang CP; Hsu CC; Hung WC; Yu TH; Wu CC; Tsai IT; Tang WH; Chung FM; Houng JY; Lee YJ; Lu YC
BMC Cardiovasc Disord; 2019 Jun; 19(1):153. PubMed ID: 31234795
[TBL] [Abstract][Full Text] [Related]
15. Altered Serum n-6 Polyunsaturated Fatty Acid Profile and Risks of Mortality and Cardiovascular Events in a Cohort of Hemodialysis Patients.
Kuwamura Y; Shoji T; Okute Y; Yamazaki Y; Motoyama K; Morioka T; Mori K; Fukumoto S; Tsujimoto Y; Shioi A; Emoto M; Inaba M
J Ren Nutr; 2018 Jan; 28(1):54-63. PubMed ID: 29089279
[TBL] [Abstract][Full Text] [Related]
16. Circulating proteins as predictors of cardiovascular mortality in end-stage renal disease.
Feldreich T; Nowak C; Fall T; Carlsson AC; Carrero JJ; Ripsweden J; Qureshi AR; Heimbürger O; Barany P; Stenvinkel P; Vuilleumier N; Kalra PA; Green D; Ärnlöv J
J Nephrol; 2019 Feb; 32(1):111-119. PubMed ID: 30499038
[TBL] [Abstract][Full Text] [Related]
17. FABP4 and Cardiovascular Events in Peripheral Arterial Disease.
Höbaus C; Herz CT; Pesau G; Wrba T; Koppensteiner R; Schernthaner GH
Angiology; 2018 May; 69(5):424-430. PubMed ID: 28847153
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein apheresis reduces adipocyte fatty acid-binding protein serum levels.
Lamounier-Zepter V; Look C; Ehrhart-Bornstein M; Bornstein SR; Fischer S; Julius U
Atheroscler Suppl; 2013 Jan; 14(1):129-34. PubMed ID: 23357154
[TBL] [Abstract][Full Text] [Related]
19. Fatty Acid-Binding Protein 4 in Cardiovascular and Metabolic Diseases.
Furuhashi M
J Atheroscler Thromb; 2019 Mar; 26(3):216-232. PubMed ID: 30726793
[TBL] [Abstract][Full Text] [Related]
20. Independent and Distinct Associations of FABP4 and FABP5 With Metabolic Parameters in Type 2 Diabetes Mellitus.
Furuhashi M; Sakuma I; Morimoto T; Higashiura Y; Sakai A; Matsumoto M; Sakuma M; Shimabukuro M; Nomiyama T; Arasaki O; Node K; Ueda S
Front Endocrinol (Lausanne); 2020; 11():575557. PubMed ID: 33071982
[No Abstract] [Full Text] [Related]
[Next] [New Search]
